Jie Dang

Jie Dang


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2014 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
SSShan Shan
Shan Shan
JDJie Dang
Jie Dang
JLJiangxia Li
Jiangxia Li
ZYZe Yang
Ze Yang
HZHailing Zhao
Hailing Zhao
QLQiji Liu
Qiji Liu
Introduction: ETS1 is a negative regulator of the Th17 differentiation gene and plays a central role in the pathogenesis of autoimmune diseases. We aimed to investigate whether polymorphisms in ETS1 confer susceptibility to ankylosing spondylitis (AS) in Han Chinese. Methods: We selected seven single nucleotide polymorphisms (SNPs) within ETS1 based on HapMap data and previous genome-wide association study. Genotyping involved the TaqMan method in 1,015 patients with AS and 1,132 healthy controls from Shandong Province, and 352 AS patients and 400 healthy controls from Ningxia, a northwest region in China. Gene expression was determined by real-time PCR. Results: The SNP rs1128334 was strongly associated with AS (odds ratio 1.204, 95% confidence interval 1.06-1.37; P = 0.005). This association was confiexrmed in the Ningxia population (P = 0.015). Carriers of the haplotype TAT for rs12574073, rs1128334 and rs4937333 were associated with increased risk of AS and haplotype CGC with reduced risk as compared to controls. In addition, ETS1 expression was lower in AS patients than controls. The risk allele A of rs1128334 and haplotype A-T of rs1128334 and rs4937333 were associated with decreased expression of ETS1. Conclusions: Common variants in ETS1 may contribute to AS susceptibility in Han Chinese people.

5 March 2013 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
RQRongfang Qiu
Rongfang Qiu
YYYang Yang
Yang Yang
HZHailing Zhao
Hailing Zhao
JLJiangxia Li
Jiangxia Li
QXQian Xin
Qian Xin
QLQiji Liu
Qiji Liu
Orosomucoid‐like 3 (ORMDL3) has been associated with asthma and a series of autoimmune disorders, and is involved in endoplasmic reticulum‐mediated inflammatory responses. However, its clinical significance and the molecular mechanism underlying its expression are still largely unclear. To elucidate the mechanisms of human ORMDL3 transcriptional regulation, we cloned a 1.5 kb genomic DNA fragment containing the putative promoter region and evaluated its transcriptional activity in a luciferase reporter system by deletion analysis. We identified a 68 bp region that functions as a minimal promoter. Bioinformatics analysis predicted that the −64 to −56 bp region contained a signal transducer and activator of transcription 6 (STAT6) binding site. Electrophoretic mobility shift assay and chromatin immunoprecipitation demonstrated that STAT6 bound to its binding site within the ORMDL3 promoter. STAT6 over‐expression or knockdown trans‐activated or trans‐inhibited, respectively, the ORMDL3 promoter containing the STAT6‐binding motif. Treatment with interleukins 4 or 13 increased ORMDL3 promoter activity as well as endogenous ORMDL3 expression. Immunoprecipitation and ChIP/Re‐ChIP assays revealed that STAT6 and p300 exist in the same protein complex that binds to the ORMDL3 promoter. Our study confirmed that STAT6 plays important roles in regulating the expression of human ORMDL3 by directly binding to the promoter region, which may shed light on a possible role in various human diseases.Structured digital p300 physically interacts with STAT6 by anti bait coimmunoprecipitation (View Interaction: 1, 2)

7 November 2012 in American Journal of Human Biology
Verified
Journal Article
Closed access
PDF file
CZChuan Zhang
Chuan Zhang
JDJie Dang
Jie Dang
LPLiguo Pei
Liguo Pei
MGMengjing Guo
Mengjing Guo
HZHao Zhu
Hao Zhu
ZHZhenghao Huo
Zhenghao Huo

6 May 2021 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
SZShaolan Zhou
Shaolan Zhou
JZJing Zhang
Jing Zhang
PLPengfei Luan
Pengfei Luan
ZMZhanbing Ma
Zhanbing Ma
JDJie Dang
Jie Dang
ZHZhenghao Huo
Zhenghao Huo
Objective. To investigate microRNA (miRNA) expression profiles in individuals with systemic lupus erythematosus (SLE) and identify the valuable miRNA biomarkers in diagnosing and monitoring SLE. Methods. Next-generation sequencing (NGS) was performed to assess miRNA amounts in peripheral blood mononuclear cells (PBMCs) from four SLE cases and four healthy controls. Quantitative polymerase chain reaction (qPCR) was carried out for validating candidate miRNAs in 32 SLE cases and 32 healthy controls. In addition, receiver operating characteristic (ROC) curve analysis was completed to evaluate diagnostic performance. Finally, the associations of candidate miRNAs with various characteristics of SLE were analyzed. Results. A total of 157 miRNAs were upregulated, and 110 miRNAs were downregulated in PBMCs from SLE cases in comparison to healthy controls, of which the increase of miR-183-5p and decrease of miR-374b-3p were validated by qPCR and both showed good diagnostic performance for SLE diagnosis. Besides, miR-183-5p expression levels displayed a positive association with SLE disease activity index (SLEDAI) and anti-dsDNA antibody amounts. Conclusion. Our data indicated that miR-183-5p is a promising biomarker of SLE.

30 January 2019
Verified
Conference Paper
Open access
PDF file
JDJie Dang
Jie Dang
HWHongbin Wang
Hongbin Wang
HKHui Kang
Hui Kang
Currently, the major groups construction in higher vocational colleges gets growing attention. The related studies about conception, content and mechanism of major groups construction are springing up. This paper analyzes the current status of major groups development in higher vocational colleges, which finds that there exist a series of problems like...

4 September 2021 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
SZShaolan Zhou
Shaolan Zhou
JZJing Zhang
Jing Zhang
PLPengfei Luan
Pengfei Luan
ZMZhanbing Ma
Zhanbing Ma
JDJie Dang
Jie Dang
ZHZhenghao Huo
Zhenghao Huo
[This corrects the article DOI: 10.1155/2021/5547635.].